Comment: Proton Pump Inhibitor Formulary Considerations in the Acutely Ill. Part 1: Pharmacology,Pharmacodynamics,and Available Formulations

Abstract

Get full access to this article

View all access options for this article.

References

Devlin

, Welage

, Olsen

. Proton pump inhibitor formulary considerations in the acutely ill. Part 1: pharmacology, pharmacodynamics, and available formulations. Ann Pharmacother 2005;39:1667–77. Epub 23 Aug 2005. DOI 10.1345/aph.1G126

Prescribing information. Zegerid (omeprazole). San Diego: Santarus, January 2005.

Conrad

, Gabrielli

, Margolis

A randomized double-blind comparison of immediate-release omeprazole oral suspension vs. intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005;33:760–5.

Messaouik

, Sautou-Miranda

, Bagel-Boithias

, Chopineau

Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. Int J Pharm 2005;299:65–72.

Data on file. San Diego: Santarus, 2004.